| James M Harvey, MD | |
|
6601 Dan Danciger, Suite 100, Fort Worth, TX 76133-4953 | |
| (817) 294-2531 | |
| (817) 294-7425 |
| Full Name | James M Harvey |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 34 Years |
| Location | 6601 Dan Danciger, Fort Worth, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427076926 | NPI | - | NPPES |
| 080193339 | Other | RAILROAD MEDICARE | |
| 047136902 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | H9981 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Health Care Pllc | 7214840867 | 322 |
News Archive
The first speech recognition aid to give a voice to people with severe speech impairment is the flagship technology on display today [19 November] at the launch of the University of Sheffield's new Centre for Assistive Technology and Connected Healthcare.
CSSi, the leader in patient recruitment solutions for the clinical research industry, announced today that President Chris Trizna has been honored as one of the PharmaVOICE 100, an annual list from PharmaVOICE magazine of the most inspiring people in the life-sciences industry.
According to researchers cancer may soon be detectable using a breath test. They are now developing sensors that can detect chemical markers of lung, breast, bowel and prostate cancer in a person's breath. The new portable device has been purported as an "electronic nose" that can detect early cancers. As a cancer grows, the surface of the cells emits chemicals. The research found that sensors – involving gold nanoparticles – could be used to detect these chemicals in the breath.
APCER Pharma announced that LPC Pharma Group is outsourcing its pharmacovigilance/drug safety operations to APCER.
› Verified 9 days ago
| Entity Name | Texas Health Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477628873 PECOS PAC ID: 7214840867 Enrollment ID: O20031110000388 |
News Archive
The first speech recognition aid to give a voice to people with severe speech impairment is the flagship technology on display today [19 November] at the launch of the University of Sheffield's new Centre for Assistive Technology and Connected Healthcare.
CSSi, the leader in patient recruitment solutions for the clinical research industry, announced today that President Chris Trizna has been honored as one of the PharmaVOICE 100, an annual list from PharmaVOICE magazine of the most inspiring people in the life-sciences industry.
According to researchers cancer may soon be detectable using a breath test. They are now developing sensors that can detect chemical markers of lung, breast, bowel and prostate cancer in a person's breath. The new portable device has been purported as an "electronic nose" that can detect early cancers. As a cancer grows, the surface of the cells emits chemicals. The research found that sensors – involving gold nanoparticles – could be used to detect these chemicals in the breath.
APCER Pharma announced that LPC Pharma Group is outsourcing its pharmacovigilance/drug safety operations to APCER.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James M Harvey, MD Po Box 961205, Fort Worth, TX 76161-1205 Ph: (817) 740-8400 | James M Harvey, MD 6601 Dan Danciger, Suite 100, Fort Worth, TX 76133-4953 Ph: (817) 294-2531 |
News Archive
The first speech recognition aid to give a voice to people with severe speech impairment is the flagship technology on display today [19 November] at the launch of the University of Sheffield's new Centre for Assistive Technology and Connected Healthcare.
CSSi, the leader in patient recruitment solutions for the clinical research industry, announced today that President Chris Trizna has been honored as one of the PharmaVOICE 100, an annual list from PharmaVOICE magazine of the most inspiring people in the life-sciences industry.
According to researchers cancer may soon be detectable using a breath test. They are now developing sensors that can detect chemical markers of lung, breast, bowel and prostate cancer in a person's breath. The new portable device has been purported as an "electronic nose" that can detect early cancers. As a cancer grows, the surface of the cells emits chemicals. The research found that sensors – involving gold nanoparticles – could be used to detect these chemicals in the breath.
APCER Pharma announced that LPC Pharma Group is outsourcing its pharmacovigilance/drug safety operations to APCER.
› Verified 9 days ago
Jonathan A Lazarini, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1500 S Main St, Fort Worth, TX 76104 Phone: 903-353-2265 | |
Mrs. Adeline Galvez, Family Medicine Medicare: Medicare Enrolled Practice Location: 1300 W Terrell Ave Ste 270, Fort Worth, TX 76104 Phone: 817-250-4987 | |
Fomundam Newnton Mbuh, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 4759 South Fwy Ste 101, Fort Worth, TX 76115 Phone: 817-382-0005 | |
Dr. Joane Baumer, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1500 S Main St, Family Medicine Center, Fort Worth, TX 76104 Phone: 817-335-1034 | |
Evelyn Tobias-merrill, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2825 Stadium Dr, Fort Worth, TX 76109 Phone: 817-257-7940 | |
Dr. Michael David Carletti, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 855 Montgomery St, Fort Worth, TX 76107 Phone: 817-735-0278 | |
Jonathan Patrick Angel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 N Beach St Ste 104, Fort Worth, TX 76111 Phone: 817-831-1750 Fax: 817-831-1750 |